Prevalence and clinical outcome of arrhythmic mitral valve prolapse in athletes

Back

ESC Premium Access

Prevalence and clinical outcome of arrhythmic mitral valve prolapse in athletes

Session: Management of athletes with heart disease

Topic: Sports cardiology

Speaker: Doctor S. Caselli (Zurich, CH)

Event: ESC Congress 2017

Congress Presentation

About the speaker

Doctor Stefano Caselli

Hirslanden-Klinik im Park, Zurich (Switzerland)

13 presentations

3 followers

3 more presentations in this session

State of the Art: management of athletes with heart disease

Speaker: Professor S. Sharma (London, GB)

Access

Slides

Video

J-point elevation in subjects with TWI V1-V4 does not differentiate between arrhythmogenic right ventricular cardiomyopathy (ARVC) and healthy athletes when matched for age, sex and ethnicity.

Speaker: Doctor M. Brosnan (Melbourne, AU)

Legal aspects of disqualification recommendations for elite athletes with cardiovascular disease

Speaker: Professor B. Merkely (Budapest, HU)

Access

Slides

Video

Access the full session

Management of athletes with heart disease

Speakers: Doctor S. Caselli, Professor S. Sharma, Doctor M. Brosnan, Professor B. Merkely

Access

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

Prevalence and clinical outcome of arrhythmic mitral valve prolapse in athletes

About the speaker

Doctor Stefano Caselli

3 more presentations in this session

State of the Art: management of athletes with heart disease

J-point elevation in subjects with TWI V1-V4 does not differentiate between arrhythmogenic right ventricular cardiomyopathy (ARVC) and healthy athletes when matched for age, sex and ethnicity.

Legal aspects of disqualification recommendations for elite athletes with cardiovascular disease

Access the full session

Management of athletes with heart disease

About the event

ESC Congress 2017

ESC 365 is supported by